8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
LABCORP HOLDINGS INC. (LH)

Labcorp filed an 8‑K on Feb 17, 2026: Exhibit 99.1 is a press release titled “Labcorp Announces 2025…

Filed with the SEC on · Summarized by InvestorsBot

Labcorp filed an 8‑K on Feb 17, 2026: Exhibit 99.1 is a press release titled “Labcorp Announces 2025 Fourth Quarter and Full Year Results.” Earnings release published — review for revenue, EPS and guidance. $LH 📢 #Labcorp #earnings #healthcare

Exhibit 104 (Inline XBRL cover page) also attached. 8‑K signed Feb 17, 2026 by Kathryn W. Kyle, EVP & Chief Legal Officer. Structured data included for analyst review. $LH 🧾 #SECfiling #transparency

Investor action: read the Feb 17 press release for Q4/FY2025 metrics, guidance and any one‑time items—those can move $LH price. Expect potential volatility after disclosure. $LH 🔍📈 #Labcorp #earnings

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from LABCORP HOLDINGS INC.

Labcorp ($LH) 8‑K: Term Loan Credit Agreement dated Mar 20, 2026 among Labcorp Holdings and lenders;…

8-K · March 20, 2026

LABCORP ($LH) 8-K filed 2026-03-20 — Item 2.03 states it incorporates Item 1.01 by reference re: creation…

8-K · March 20, 2026

BREAKING: Labcorp ($LH) CONFIRMED a $750M senior unsecured term loan — fully funded Mar 20, 2026; matures…

8-K · March 20, 2026

LabCorp ($LH) filed a Form 8‑K on Feb 17, 2026 reporting Item 2.02 — Results of Operations and Financial…

8-K · February 17, 2026

Labcorp ($LH) filed an 8‑K on Feb 9, 2026 furnishing a press release (Exhibit 99.1) and an Inline XBRL…

8-K · February 9, 2026

Labcorp ($LH) appointed Dr.

8-K · February 9, 2026